DocGo Inc.

NASDAQ:DCGO

Medical - Care Facilities

Healthcare
$0.71 -4.29%

-$0.02 today

Market cap
$70.14M
Beta
1.00
P/E (TTM)
-0.3
EPS (TTM)
-$1.90
52W Low $0.49High $1.78

Volume 1.64M

Average 0.87M

DCGO Deferred Income Tax

The difference between tax expense recognized and tax actually paid in cash during the period.

DocGo Inc.NASDAQ: DCGO

Deferred Income Tax · Q1 FY2026 · quarter ended Mar 2026

Deferred income tax dips below year-ago levels

Q1 FY2026 deferred income tax of $253.78K (cash outflow) fell 93.5% year over year, behind the +2918.4% change in trailing-twelve-month deferred income tax.

Context

  • Deferred income tax amounted to 2.4% of revenue in FY2025, up 1.8 pp from a year earlier.
  • Deferred income tax increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -93.5% toward the trailing-twelve-month pace of +2918.4%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$253.78K-100.8% QoQ
Last fiscal yearDec 2025
$7.75M+123.4% YoY
LTMMar 2026
$11.42M+2918.4% YoY
Deferred Income Tax past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-93.5%——
1 year+123.4%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Deferred Income Tax history

USD · from the cash flow

Latest · FY2025
7.75M USD
Year-over-year change
+123.4%

Deferred Income Tax vs competitors

How DCGO compares with its peers on the latest reported figures

  • DCGO's LTM Mar 2026 deferred income tax of $11.42M is the largest of the 9 companies compared; the peer median is $0.
  • Deferred income tax amounts to 3.8% of revenue for DCGO, versus a peer median of 0.0%.
DCGO Competitors Peer median
Deferred Income Tax for DCGO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
DCGODocGo Inc.LTM Mar 2026$11.42M +2918.4%—3.8%
IMMXImmix Biopharma, Inc.LTM Mar 2026$0 ———
OVIDOvid Therapeutics Inc.LTM Mar 2026$0 ——0.0%
PRLDPrelude Therapeutics IncorporatedLTM Mar 2026$0 ——0.0%
MGNXMacroGenics, Inc.LTM Mar 2026$0 ——0.0%
RCELAVITA Medical, Inc.LTM Mar 2026$0 ——0.0%
VANIVivani Medical, Inc.LTM Mar 2026$0 ———
COYACoya Therapeutics, Inc.LTM Mar 2026$0 ——0.0%
MBOTMicrobot Medical Inc.LTM Mar 2026$0 ——0.0%
Peer median (excluding DCGO) $0——0.0%

Competitors are the stored peer set for DCGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income19.18M30.74M6.86M19.99M(196.37M)
Depreciation & Amortization7.07M10.57M16.43M15.88M15.66M
Deferred Income Tax(630.38K)(9.96M)(1.98M)3.47M7.75M
Stock-Based Compensation1.38M8.05M20.97M13.63M17.44M
Change in Working Capital(28.8M)(13.18M)(113.12M)19.52M81.66M
Accounts Receivables(58M)(8.42M)(160.52M)41.27M112.5M
Inventory00000
Accounts Payables11.88M3.64M(1.78M)8.56M(17.64M)
Other Working Capital17.31M(8.4M)49.18M(30.32M)(13.19M)
Other Non-Cash Items(142.67K)2.64M6.62M(2.16M)108.31M
Operating Cash Flow(1.95M)28.87M(64.22M)70.34M34.45M
Capital Expenditures(6.66M)(5.5M)(10.13M)(5.84M)(7.43M)
Acquisitions (Net)(1.96M)(32.95M)(19.46M)(310.45K)(16.4M)
Purchases of Investments(655.88K)00(5M)0
Sales of Investments655.88K00013.16M
Other Investing Activities(1.82M)(2.3M)(2.84M)(1.73M)(31.3M)
Investing Cash Flow(8.59M)(38.45M)(29.88M)(10.87M)(39.08M)
Debt Repayment(2.82M)(3.94M)20.7M613.55K(35.17M)
Common Stock Issued178.1M01.58M00
Common Stock Repurchased(479.33K)(3.73M)0(13.76M)(10.83M)
Dividends Paid000(1.29T)0
Other Financing Activities(19.6M)1.49M(21.17M)1.29T(4.82M)
Financing Cash Flow155.21M(6.18M)1.12M(24.15M)(50.82M)
Effect of Forex Changes(21.41K)761.23K1.09M(190.64K)595.8K
Net Change in Cash144.65M(15M)(91.89M)35.12M(54.85M)
Free Cash Flow(8.6M)23.37M(74.35M)64.5M27.02M

DocGo Inc.

NASDAQ:DCGO

Intrinsic Alpha fair value

Locked

Current Price

$0.71

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.